Comparison of insulin degludec with insulin glargine in insulin‐naive subjects with Type 2 diabetes: a 2‐year randomized, treat‐to‐target trial
Identifieur interne : 000708 ( Main/Exploration ); précédent : 000707; suivant : 000709Comparison of insulin degludec with insulin glargine in insulin‐naive subjects with Type 2 diabetes: a 2‐year randomized, treat‐to‐target trial
Auteurs : H. W. Rodbard [États-Unis] ; B. Cariou [France] ; B. Zinman [Canada] ; Y. Handelsman [États-Unis] ; A. Philis-Tsimikas [États-Unis] ; T. V. Skj Th [Danemark] ; A. Rana [Danemark] ; C. Mathieu [Belgique]Source :
- Diabetic Medicine [ 0742-3071 ] ; 2013-11.
Abstract
The aim of this study was to compare long‐term safety and efficacy of the basal insulin analogue degludec with glargine in insulin‐naive subjects with Type 2 diabetes.
Url:
DOI: 10.1111/dme.12303
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000C92
- to stream Istex, to step Curation: 000C83
- to stream Istex, to step Checkpoint: 000365
- to stream Main, to step Merge: 000709
- to stream Main, to step Curation: 000708
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Comparison of insulin degludec with insulin glargine in insulin‐naive subjects with Type 2 diabetes: a 2‐year randomized, treat‐to‐target trial</title><author><name sortKey="Rodbard, H W" sort="Rodbard, H W" uniqKey="Rodbard H" first="H. W." last="Rodbard">H. W. Rodbard</name></author><author><name sortKey="Cariou, B" sort="Cariou, B" uniqKey="Cariou B" first="B." last="Cariou">B. Cariou</name></author><author><name sortKey="Zinman, B" sort="Zinman, B" uniqKey="Zinman B" first="B." last="Zinman">B. Zinman</name></author><author><name sortKey="Handelsman, Y" sort="Handelsman, Y" uniqKey="Handelsman Y" first="Y." last="Handelsman">Y. Handelsman</name></author><author><name sortKey="Philis Simikas, A" sort="Philis Simikas, A" uniqKey="Philis Simikas A" first="A." last="Philis-Tsimikas">A. Philis-Tsimikas</name></author><author><name sortKey="Skj Th, T V" sort="Skj Th, T V" uniqKey="Skj Th T" first="T. V." last="Skj Th">T. V. Skj Th</name></author><author><name sortKey="Rana, A" sort="Rana, A" uniqKey="Rana A" first="A." last="Rana">A. Rana</name></author><author><name sortKey="Mathieu, C" sort="Mathieu, C" uniqKey="Mathieu C" first="C." last="Mathieu">C. Mathieu</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:A28BE9CAC594110081CCE842562F5BA985891B2C</idno><date when="2013" year="2013">2013</date><idno type="doi">10.1111/dme.12303</idno><idno type="url">https://api.istex.fr/document/A28BE9CAC594110081CCE842562F5BA985891B2C/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000C92</idno><idno type="wicri:Area/Istex/Curation">000C83</idno><idno type="wicri:Area/Istex/Checkpoint">000365</idno><idno type="wicri:doubleKey">0742-3071:2013:Rodbard H:comparison:of:insulin</idno><idno type="wicri:Area/Main/Merge">000709</idno><idno type="wicri:Area/Main/Curation">000708</idno><idno type="wicri:Area/Main/Exploration">000708</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Comparison of insulin degludec with insulin glargine in insulin‐naive subjects with Type 2 diabetes: a 2‐year randomized, treat‐to‐target trial</title><author><name sortKey="Rodbard, H W" sort="Rodbard, H W" uniqKey="Rodbard H" first="H. W." last="Rodbard">H. W. Rodbard</name><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Endocrine and Metabolic Consultants, MD, Rockville</wicri:regionArea><wicri:noRegion>Rockville</wicri:noRegion></affiliation></author><author><name sortKey="Cariou, B" sort="Cariou, B" uniqKey="Cariou B" first="B." last="Cariou">B. Cariou</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Clinique d'Endocrinologie, l'Institut du Thorax, Nantes, CHU Nantes</wicri:regionArea><wicri:noRegion>CHU Nantes</wicri:noRegion><wicri:noRegion>CHU Nantes</wicri:noRegion></affiliation></author><author><name sortKey="Zinman, B" sort="Zinman, B" uniqKey="Zinman B" first="B." last="Zinman">B. Zinman</name><affiliation wicri:level="4"><country xml:lang="fr">Canada</country><wicri:regionArea>Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, ON, Toronto</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Handelsman, Y" sort="Handelsman, Y" uniqKey="Handelsman Y" first="Y." last="Handelsman">Y. Handelsman</name><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Metabolic Institute of America, CA, Tarzana</wicri:regionArea><wicri:noRegion>Tarzana</wicri:noRegion></affiliation></author><author><name sortKey="Philis Simikas, A" sort="Philis Simikas, A" uniqKey="Philis Simikas A" first="A." last="Philis-Tsimikas">A. Philis-Tsimikas</name><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Scripps Whittier Diabetes Institute, CA, La Jolla</wicri:regionArea><wicri:noRegion>La Jolla</wicri:noRegion></affiliation></author><author><name sortKey="Skj Th, T V" sort="Skj Th, T V" uniqKey="Skj Th T" first="T. V." last="Skj Th">T. V. Skj Th</name><affiliation wicri:level="1"><country xml:lang="fr">Danemark</country><wicri:regionArea>Novo Nordisk A/S, Søborg</wicri:regionArea><wicri:noRegion>Søborg</wicri:noRegion></affiliation></author><author><name sortKey="Rana, A" sort="Rana, A" uniqKey="Rana A" first="A." last="Rana">A. Rana</name><affiliation wicri:level="1"><country xml:lang="fr">Danemark</country><wicri:regionArea>Novo Nordisk A/S, Søborg</wicri:regionArea><wicri:noRegion>Søborg</wicri:noRegion></affiliation></author><author><name sortKey="Mathieu, C" sort="Mathieu, C" uniqKey="Mathieu C" first="C." last="Mathieu">C. Mathieu</name><affiliation wicri:level="1"><country xml:lang="fr">Belgique</country><wicri:regionArea>UZ Leuven, University of Leuven, Leuven</wicri:regionArea><wicri:noRegion>Leuven</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Diabetic Medicine</title><title level="j" type="abbrev">Diabet. Med.</title><idno type="ISSN">0742-3071</idno><idno type="eISSN">1464-5491</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><date type="published" when="2013-11">2013-11</date><biblScope unit="volume">30</biblScope><biblScope unit="issue">11</biblScope><biblScope unit="page" from="1298">1298</biblScope><biblScope unit="page" to="1304">1304</biblScope></imprint><idno type="ISSN">0742-3071</idno></series><idno type="istex">A28BE9CAC594110081CCE842562F5BA985891B2C</idno><idno type="DOI">10.1111/dme.12303</idno><idno type="ArticleID">DME12303</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0742-3071</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">The aim of this study was to compare long‐term safety and efficacy of the basal insulin analogue degludec with glargine in insulin‐naive subjects with Type 2 diabetes.</div></front></TEI><affiliations><list><country><li>Belgique</li><li>Canada</li><li>Danemark</li><li>France</li><li>États-Unis</li></country><region><li>Ontario</li></region><settlement><li>Toronto</li></settlement><orgName><li>Université de Toronto</li></orgName></list><tree><country name="États-Unis"><noRegion><name sortKey="Rodbard, H W" sort="Rodbard, H W" uniqKey="Rodbard H" first="H. W." last="Rodbard">H. W. Rodbard</name></noRegion><name sortKey="Handelsman, Y" sort="Handelsman, Y" uniqKey="Handelsman Y" first="Y." last="Handelsman">Y. Handelsman</name><name sortKey="Philis Simikas, A" sort="Philis Simikas, A" uniqKey="Philis Simikas A" first="A." last="Philis-Tsimikas">A. Philis-Tsimikas</name></country><country name="France"><noRegion><name sortKey="Cariou, B" sort="Cariou, B" uniqKey="Cariou B" first="B." last="Cariou">B. Cariou</name></noRegion></country><country name="Canada"><region name="Ontario"><name sortKey="Zinman, B" sort="Zinman, B" uniqKey="Zinman B" first="B." last="Zinman">B. Zinman</name></region></country><country name="Danemark"><noRegion><name sortKey="Skj Th, T V" sort="Skj Th, T V" uniqKey="Skj Th T" first="T. V." last="Skj Th">T. V. Skj Th</name></noRegion><name sortKey="Rana, A" sort="Rana, A" uniqKey="Rana A" first="A." last="Rana">A. Rana</name></country><country name="Belgique"><noRegion><name sortKey="Mathieu, C" sort="Mathieu, C" uniqKey="Mathieu C" first="C." last="Mathieu">C. Mathieu</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Belgique/explor/OpenAccessBelV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000708 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000708 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Belgique
|area= OpenAccessBelV2
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:A28BE9CAC594110081CCE842562F5BA985891B2C
|texte= Comparison of insulin degludec with insulin glargine in insulin‐naive subjects with Type 2 diabetes: a 2‐year randomized, treat‐to‐target trial
}}
| This area was generated with Dilib version V0.6.25. |  |